YM-155 potentiates the effect of ABT-737 in malignant human glioma cells via survivin and Mcl-1 downregulation in an EGFR-dependent context.
Saved in:
| Title: | YM-155 potentiates the effect of ABT-737 in malignant human glioma cells via survivin and Mcl-1 downregulation in an EGFR-dependent context. |
|---|---|
| Authors: | Jane EP; Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, PA 15224, USA., Premkumar DR, DiDomenico JD, Hu B, Cheng SY, Pollack IF |
| Source: | Molecular cancer therapeutics [Mol Cancer Ther] 2013 Mar; Vol. 12 (3), pp. 326-38. Date of Electronic Publication: 2013 Jan 16. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
